Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT05114148 · UNKNOWN

Trial details

NCT number: NCT05114148
Sponsor: UMC Utrecht
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2022-03-01
Primary completion: 2024-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.